Alignment Healthcare Inc
For the period ended Jun 30, 2024. Filed Aug 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 1, 2024
ALHC$7.27-1.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Operations
(amounts in thousands, except share and per share amounts)
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | |
| Revenues: | ||||
| Earned premiums | $674,094 | $456,877 | $1,295,650 | $891,689 |
| Other | 7,192 | 5,502 | 14,237 | 9,845 |
| Total revenues | 681,286 | 462,379 | 1,309,887 | 901,534 |
| Expenses: | ||||
| Medical expenses | 605,312 | 410,644 | 1,178,530 | 806,959 |
| Selling, general, and administrative expenses | 87,863 | 70,199 | 178,375 | 140,607 |
| Depreciation and amortization | 6,493 | 5,195 | 12,470 | 10,116 |
| Total expenses | 699,668 | 486,038 | 1,369,375 | 957,682 |
| Loss from operations | (18,382) | (23,659) | (59,488) | (56,148) |
| Other expenses: | ||||
| Interest expense | 5,691 | 5,262 | 11,118 | 10,281 |
| Other income, net | (92) | (428) | (50) | (566) |
| Total other expenses | 5,599 | 4,834 | 11,068 | 9,715 |
| Loss before income taxes | (23,981) | (28,493) | (70,556) | (65,863) |
| Provision for income taxes | 22 | 1 | 22 | 2 |
| Net loss | $(24,003) | $(28,494) | $(70,578) | $(65,865) |
| Less: Net (income) loss attributable to noncontrolling interest | (7) | 17 | 47 | 104 |
| Net loss attributable to Alignment Healthcare, Inc. | $(24,010) | $(28,477) | $(70,531) | $(65,761) |
| Total weighted-average common shares outstanding - basic and diluted | 190,891,787 | 185,991,460 | 189,948,725 | 184,560,652 |
| Net loss per share - basic and diluted | $(0.13) | $(0.15) | $(0.37) | $(0.36) |
Condensed Consolidated Statements of Stockholders' Equity
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | AccumulatedDeficit | Noncontrolling Interest | Total | |
| Balance at March 31, 2024 | 191,156,569 | $191 | $1,057,519 | $(926,779) | $1,086 | $132,017 |
| Net loss | — | — | — | (24,010) | 7 | (24,003) |
| Issuance of common stock upon vesting of restricted stock units | 80,178 | — | — | — | — | — |
| Equity-based compensation | — | — | 16,784 | — | — | 16,784 |
| Balance at June 30, 2024 | 191,236,747 | $191 | $1,074,303 | $(950,789) | $1,093 | $124,798 |
| Common Stock | ||||||
|---|---|---|---|---|---|---|
| Shares | Amount | Additional Paid-In Capital | AccumulatedDeficit | Noncontrolling interest | Total | |
| Balance at March 31, 2023 | 188,475,278 | $188 | $992,158 | $(769,525) | $1,119 | $223,940 |
| Net loss | — | — | — | (28,477) | (17) | (28,494) |
| Issuance of common stock upon vesting of restricted stock units | 43,195 | — | — | — | — | — |
| Forfeitures | (5,708) | — | — | — | — | — |
| Equity-based compensation | — | — | 15,636 | — | — | 15,636 |
| Noncontrolling interest attributable to subsidiary | — | — | — | — | 30 | 30 |
| Balance at June 30, 2023 | 188,512,765 | $188 | $1,007,794 | $(798,002) | $1,132 | $211,112 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.